Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Lin

Showing results (1271-1280 of 1,285) with videos related to

Pageof 129
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Nature Genetics|September 16, 2003
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resourceWei Hu, Qing Yan, Da-Kang Shen, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Annals of the Rheumatic Diseases|May 22, 2024
CD8<sup>+</sup> tissue-resident memory T cells are expanded in primary Sjögren's disease and can be therapeutically targeted by CD103 blockadeDaniele Mauro, Xiang Lin, Elena Pontarini, et al.
Oncotarget|December 15, 2015
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinomaXiao-Bin Cui, Su Li, Ting-Ting Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)Feng Wang, Ming-Ming He, Jian Xiao, et al.
The EMBO Journal|September 18, 2023
Infection and inflammation stimulate expansion of a CD74<sup>+</sup> Paneth cell subset to regulate disease progressionIyshwarya Balasubramanian, Sheila Bandyopadhyay, Juan Flores, et al.
The Journal of Infection|February 16, 2025
Past, present and future epidemiology of echinococcosis in China based on nationwide surveillance data 2004-2022Xu Wang, Yan Kui, Chui-Zhao Xue, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Integrating predictive coding and a user-centric interface for enhanced auditing and quality in cancer registry dataHong-Jie Dai, Chien-Chang Chen, Tatheer Hussain Mir, et al.
Pageof 129

Showing results (1271-1280 of 1,285) with videos related to

Sort By:
Pageof 129
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in GliomasShiyou Wei, Delong Yin, Shengnan Yu, et al.
Nature Genetics|September 16, 2003
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resourceWei Hu, Qing Yan, Da-Kang Shen, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Annals of the Rheumatic Diseases|May 22, 2024
CD8<sup>+</sup> tissue-resident memory T cells are expanded in primary Sjögren's disease and can be therapeutically targeted by CD103 blockadeDaniele Mauro, Xiang Lin, Elena Pontarini, et al.
Oncotarget|December 15, 2015
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinomaXiao-Bin Cui, Su Li, Ting-Ting Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 2021
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in GliomasShengnan Yu, Shiyou Wei, Milan Savani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)Feng Wang, Ming-Ming He, Jian Xiao, et al.
The EMBO Journal|September 18, 2023
Infection and inflammation stimulate expansion of a CD74<sup>+</sup> Paneth cell subset to regulate disease progressionIyshwarya Balasubramanian, Sheila Bandyopadhyay, Juan Flores, et al.
The Journal of Infection|February 16, 2025
Past, present and future epidemiology of echinococcosis in China based on nationwide surveillance data 2004-2022Xu Wang, Yan Kui, Chui-Zhao Xue, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Integrating predictive coding and a user-centric interface for enhanced auditing and quality in cancer registry dataHong-Jie Dai, Chien-Chang Chen, Tatheer Hussain Mir, et al.
Pageof 129